Dacomitinib
Definition: Dacomitinib, sold under the brand name Vizimpro, is a medication for the treatment of non-small-cell lung carcinoma (NSCLC). It is a selective and irreversible inhibitor of EGFR. Dacomitinib has advanced to several Phase III clinical trials. source: Wikipedia
- ID
- 781492009
- ID date
- 6 Sep 2021
- Previous ID
- 36812311000001102
- Name
- Dacomitinib